Differential regulation of in vivo angiogenesis by angiotensin II receptors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Differential regulation of in vivo angiogenesis by angiotensin II receptors

Published:2003-11 Issue:14 Volume:17 Page:2061-2067
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Walther Thomas¹,Menrad Andreas²,Orzechowski Hans-Dieter³,Siemeister Gerhard²,Paul Martin³,Schirner Michael²

Affiliation:

1. Department of Cardiology and PneumologyFreie Universität Berlin 12200 Berlin Germany

2. Research Laboratories of Schering AGExperimental Oncology 13342 Berlin Germany

3. Institute of Clinical Pharmacology and ToxicologyBenjamin Franklin Medical CenterFreie Universität Berlin 12200 Berlin Germany

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.03-0129com

Reference25 articles.

1. Mechanisms of angiogenesis

2. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant

3. Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis

4. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells.

5. Evidence for a novel angiotensin II receptor involved in angiogenesis in chick embryo chorioallantoic membrane;Le Noble F. A.;Am. J. Physiol.,1993

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Onco-Hypertension: A Continuously Developing Field between Cancer and Hypertension;International Journal of Molecular Sciences;2024-03-19

2. Association between 19 medication use and risk of common cancers: A cross-sectional and Mendelian randomisation study;Journal of Global Health;2024-03-15

3. Several first-line anti-hypertensives act on fibrosarcoma progression and PD1ab blockade therapy;Journal of Orthopaedic Surgery and Research;2024-02-19

4. Association between use of antihypertensive drugs and the risk of cancer: a population-based cohort study in Shanghai;BMC Cancer;2023-05-11

5. Pharmacological Utility of PPAR Modulation for Angiogenesis in Cardiovascular Disease;International Journal of Molecular Sciences;2023-01-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3